The Expanding Role of Circulating Tumor DNA in the Management of Solid Tumors: A Multidisciplinary Approach



This webinar will explore the expanding role of circulating tumor DNA (ctDNA) for assessing molecular residual disease (MRD) and monitoring treatment response in patients with solid tumors. Our panel of experts will review:

  • The use of ctDNA assays to inform shared decision-making in the adjuvant setting
  • Emerging data exploring the value of integrating MRD assays into clinical practice
  • Thought-provoking insights from real-world case studies 

Sponsored by Natera

Добавить в избранное

Вам будет интересно